Variant report
Variant | nsv946397 |
---|---|
Chromosome Location | chr1:153105217-153113166 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:153104005..153106814-chr1:153109667..153111966,2 | MCF-7 | breast: | |
2 | chr1:153104005..153106814-chr1:153109667..153111966,2 | MCF-7 | breast: | |
3 | chr1:152974698..152976690-chr1:153106639..153108366,2 | K562 | blood: | |
4 | chr1:153107195..153108706-chr1:153149900..153151455,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000163209 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115153834 | chr1:153105224-153105225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114080465 | chr1:153105241-153105242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576340979 | chr1:153105281-153105282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77193224 | chr1:153105283-153105284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565223018 | chr1:153105297-153105298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527581282 | chr1:153105311-153105312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7534523 | chr1:153105340-153105341 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs561123470 | chr1:153105362-153105363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529769114 | chr1:153105363-153105364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557349416 | chr1:153105373-153105374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565574057 | chr1:153105379-153105380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113439129 | chr1:153105384-153105385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569558324 | chr1:153105406-153105407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs199674364 | chr1:153105408-153105409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141884253 | chr1:153105409-153105410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551749701 | chr1:153105414-153105415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571636524 | chr1:153105469-153105470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534206272 | chr1:153105485-153105486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553959879 | chr1:153105502-153105503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574147531 | chr1:153105520-153105521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536352988 | chr1:153105536-153105537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556580795 | chr1:153105586-153105587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150625391 | chr1:153105597-153105598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545466256 | chr1:153105598-153105599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565260515 | chr1:153105629-153105630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572406802 | chr1:153105661-153105662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12029300 | chr1:153105663-153105664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs139690454 | chr1:153105701-153105702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539862692 | chr1:153105708-153105709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529855618 | chr1:153105756-153105757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549698474 | chr1:153105815-153105816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1604264 | chr1:153105819-153105820 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs532052753 | chr1:153105823-153105824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs485374 | chr1:153105865-153105866 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs75305201 | chr1:153105877-153105878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565301086 | chr1:153105890-153105891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527999750 | chr1:153105918-153105919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548021407 | chr1:153105930-153105931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567774185 | chr1:153105937-153105938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78234301 | chr1:153105938-153105939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75712235 | chr1:153105939-153105940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556477939 | chr1:153105943-153105944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540371004 | chr1:153105981-153105982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs149761570 | chr1:153106090-153106091 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186184352 | chr1:153106109-153106110 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79401041 | chr1:153106117-153106118 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373227198 | chr1:153106160-153106161 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572446005 | chr1:153106176-153106177 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556535711 | chr1:153106190-153106191 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553058090 | chr1:153106208-153106209 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:153100400-153107000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr1:153102600-153107800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr1:153103000-153106800 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr1:153103000-153107800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr1:153103400-153105800 | Weak transcription | Ovary | ovary |
6 | chr1:153104800-153105400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr1:153104800-153105600 | Weak transcription | Pancreas | Pancrea |
8 | chr1:153104800-153106000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:153104800-153107000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr1:153104800-153108200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr1:153105400-153105600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr1:153105600-153107200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
13 | chr1:153105800-153106000 | Enhancers | Ovary | ovary |
14 | chr1:153106000-153107000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr1:153106200-153106400 | Enhancers | Esophagus | oesophagus |
16 | chr1:153106200-153106800 | Enhancers | Gastric | stomach |
17 | chr1:153106800-153107000 | Enhancers | H9 Cell Line | embryonic stem cell |
18 | chr1:153107000-153108600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr1:153107000-153109200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr1:153107000-153118800 | Weak transcription | H9 Cell Line | embryonic stem cell |
21 | chr1:153107000-153122400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr1:153107200-153109000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
23 | chr1:153107800-153108600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
24 | chr1:153107800-153108600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
25 | chr1:153107800-153109000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
26 | chr1:153108200-153108400 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
27 | chr1:153112800-153113200 | Enhancers | Gastric | stomach |
28 | chr1:153112800-153113200 | Enhancers | Ovary | ovary |
29 | chr1:153112800-153114000 | Enhancers | Pancreas | Pancrea |